NCT05715814
- Conditions
- Chronic Disease, Disease Attributes, End Stage Kidney Disease, +15 more
- Locations
-
- Toronto General Hospital Toronto, Ontario, Canada
Clinical trial condition
Explore clinical trials studying Sodium-glucose Co-transporter-2 Inhibitors. Study availability and eligibility vary by location and protocol.
NCT05715814
NCT06398977